Source comparison
BPC-157 Studied Ligament Tear: Preclinical vs Human Evidence Comparison
Preclinical Animal Studies Controlled surgical ligament transection in rats; daily subcutaneous BPC-157 10–100 mcg/kg for 7–28 days Tensile strength recovery (80–92% vs 56–68% controls by day 14–21); organized collagen type I deposition; 40–50% faster return t
This comparison does not assign a generated winner or score.
- Preclinical Animal Studies
- Controlled surgical ligament transection in rats; daily subcutaneous BPC-157 10–100 mcg/kg for 7–28 days
- Tensile strength recovery (80–92% vs 56–68% controls by day 14–21); organized collagen type I deposition; 40–50% faster return to function
- Rat physiology ≠ human physiology; healing timelines and inflammatory cascades differ; dose translation uncertain
- Strong mechanistic evidence for angiogenesis and FAK-paxillin-mediated collagen organization. But applicability to humans unproven
- Human Case Reports
- Anecdotal self-administration protocols (dosages vary widely, 250–500 mcg daily subcutaneous); injury severity uncontrolled
- Subjective pain reduction; self-reported faster return to activity (no objective biomechanical measurement)
- No controls, no blinding, no standardized outcome measures; confounded by concurrent physical therapy and NSAIDs
- Testimonials cannot establish efficacy. Placebo effect and natural healing account for reported improvements
- Human Clinical Trials
- None published as of 2026
- N/A
- BPC-157 not FDA-approved; no Phase I, II, or III trials examining ligament injury in humans
- Absence of human trials means safety, dosing, and efficacy remain speculative
- In Vitro Studies
- Human fibroblast cell cultures treated with BPC-157 (concentrations 0.1–10 μg/mL); mechanical stretch applied to simulate loading
- Increased collagen synthesis; upregulated VEGF and TGF-β1 gene expression; fibroblast proliferation
- Cell culture ≠ whole organism; lacks immune response, vascular supply, mechanical loading complexity
- Validates receptor-level mechanisms seen in animal models, but gap to clinical application remains enormous